Skip to Content

Notice

Drug Enforcement Administration

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

By Notice dated May 14, 2013, and published in the Federal Register on May 22, 2013, 78 FR 30332, Lin Zhi International, Inc., 670 Almanor Avenue, Sunnyvale, California 94085, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances:

DrugSchedule
Tetrahydrocannabinols (7370)I
3,4-Methylenedioxymethamphet- amine (MDMA) (7405)I
Cocaine (9041)II
Oxycodone (9143)II
Hydrocodone (9193)II
Methadone (9250)II
Dextropropoxyphene, bulk (non-dosage forms) (9273)II
Morphine (9300)II

The company plans to manufacture the listed controlled substances as bulk reagents for use in drug abuse testing.

In reference to drug code 7370 the company plans to bulk manufacture a synthetic Tetrahydrocannabinol. No other activity for this drug code is authorized for this registration.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Lin Zhi International, Inc., to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Lin Zhi International, Inc., to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history.

Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.

Start Signature

Dated: November 4, 2013.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

End Signature End Preamble

[FR Doc. 2013-27486 Filed 11-15-13; 8:45 am]

BILLING CODE 4410-09-P